Pharmaceuticals

Increasing cancer prevalence is accelerating the Precision Medicine Market 2026

March 24, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Precision Medicine Market Across 2026–2030?

The precision medicine market has experienced robust growth in recent years. It is forecast to increase from $87.91 billion in 2025 to $96.27 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. This growth observed in previous periods is attributable to developments in genomic research, the reduced expense of gene sequencing, the increasing incidence of cancer and genetic disorders, higher spending on biopharmaceutical R&D, and regulatory approvals for specialized therapies.

The precision medicine market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $137.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This projected growth during the forecast period is fueled by factors such as the increasing adoption of next-generation sequencing, a growing need for tailored treatment approaches, the expanding application of AI in drug discovery, rising capital allocation towards precision diagnostics, and the incorporation of digital health platforms. Key trends characterizing this period encompass the growing uptake of companion diagnostics, a move towards individualized cancer treatments, the incorporation of multi-omics data for clinical choices, the broader application of precision medicine in the context of rare and genetic conditions, and enhanced partnerships between pharmaceutical and diagnostic companies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5301&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Precision Medicine Market?

The growing incidence of cancer is anticipated to boost the precision medicine market. Cancer stands as a primary global cause of death, with one out of every five individuals expected to develop cancer at some point in their lives. In the context of cancer, precision medicine involves analyzing DNA extracted from tumors to pinpoint mutations or other genetic abnormalities responsible for the disease. This approach enables physicians to select treatments for a specific patient’s cancer that are best suited to, or directly target, the identified tumor DNA alterations. For instance, in February 2024, the World Health Organization, a Switzerland-based specialized agency dedicated to international public health, projected over 35 million new cancer cases by 2050, representing a 77% increase from the estimated 20 million cases in 2022. Therefore, the increasing prevalence of cancer is a significant driver for the growth of the precision medicine market.

What Segmentation Levels Are Considered In The Precision Medicine Market?

The precision medicine market covered in this report is segmented –

1) By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology

2) By Application: Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications.

3) By End-Use: Pharmaceutical Companies, Diagnostic Companies, Healthcare And IT Firms, Others

Subsegments:

1) By Big Data Analytics: Predictive Analytics, Prescriptive Analytics, Data Mining

2) By Bioinformatics: Genomic Data Analysis, Proteomics Data Analysis, Metabolomics Data Analysis

3) By Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Whole Genome Sequencing

4) By Drug Discovery: Target Identification And Validation, Lead Compound Discovery, Preclinical And Clinical Trials

5) By Companion Diagnostics: Biomarker Testing, Genomic Profiling, Companion Diagnostic Tests

6) By Other Technology: Personalized Treatment Plans, Telemedicine And Digital Health Solutions, Wearable Health Technology

What Trends Are Projected To Affect The Precision Medicine Market?

Major companies operating in the precision medicine market are emphasizing innovation, such as data ingestion, which provides access to public datasets through Google Cloud’s Analytics Hub. Data ingestion describes the method of gathering and importing data from various origins into a storage system or a data processing platform. For instance, in May 2023, Google Cloud, a US-based software development company, introduced two groundbreaking AI-powered solutions designed to enhance drug discovery and precision medicine. These novel AI-powered solutions are helping to accelerate drug discovery and precision medicine for the biotech and pharmaceutical industries. Researchers can now more effectively identify protein structures and interpret genomic data, thereby improving drug development processes. These tools reduce the time-to-market for life-saving treatments and foster greater collaboration among research teams. They also offer support for multi-cloud environments to ensure seamless integration.

Which Leading Firms Are Contributing To The Growth Of The Precision Medicine Market?

Major companies operating in the precision medicine market are Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic plc, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co. Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co. Ltd., Daewoong Pharmaceutical Co.Ltd, GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Eurofarma, Biolab Farmaceutica, Cristalia, União Quimica

Read the full precision medicine market report here:

https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report

Which Regions Are Projected To Dominate The Precision Medicine Market In The Coming Years?

North America was the largest region in the precision medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Precision Medicine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=5301&type=smp

Browse Through More Reports Similar to the Global Precision Medicine Market 2026, By The Business Research Company

Precision Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report

Artificial Intelligence Ai In Precision Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-precision-medicine-global-market-report

Precision Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/precision-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795